Tailored Brain Health Insights Through Nurturing Knowledge-based Change - Stakeholder-driven, Human-centered, AI-powered Refinement for Prevention

ConditionsMCIDementia
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age40+
SponsorAlexandra Hospital

About this trial

The goal of this clinical trial is to evaluate whether an AI-powered digital brain health coaching intervention can improve modifiable brain health risk factors in community-dwelling adults aged 40 and above in Singapore.

The main question it aims to answer is: does the use of BLAZE, an AI-powered digital brain health coaching intervention, lead to a greater improvement in Brain Care Score (BCS) compared to usual care at 6 months?

Researchers will compare participants receiving BLAZE to those receiving usual care (waitlist control) to see if BLAZE leads to greater improvements in brain health risk factors, behavioural outcomes, quality of life, and cost-effectiveness.

Participants will:

* Be randomly assigned to either receive BLAZE immediately for 12 months or be placed on a waitlist receiving usual care for the first 6 months before receiving BLAZE for a further 6 months * Complete a series of assessments at baseline, 6 months, and 12 months including the Brain Care Score, physical function tests, cognitive assessments, quality of life measures, and lifestyle behaviour questionnaires * If assigned to the intervention group, interact with BLAZE via a WhatsApp-based platform that delivers personalised brain health recommendations, behavioural nudges, educational content, and goal-setting support based on their individual Brain Care Score profile

Eligibility criteria

Qualifiers

Community-dwelling adults

Aged 40 years and above at time of recruitment

Able to use a smartphone and smartphone applications

Able to provide written informed consent

Disqualifiers

Been diagnosed wotj dementia, neurocognitive disorder or any major psychiatric illness

Have severe sensory or physical disability precluding usage of the application

Terminal illness or expected survival of less than 12 months at point of recruitment

Trial design

Treatments tested in this trial

  • BLAZE (Brain health Lifestyle Action with personaliZed Engagement)

Treatment groups

350 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Alexandra Hospital

Lead sponsor

National University Hospital, Singapore

Collaborator

National University Polyclinics, Singapore

Collaborator